- $12.70bn
- $35.68bn
- $10.82bn
Jefferies quarterly profit misses estimates as asset management weighs (updated)
Jefferies Financial Group Inc reports results for the quarter ended May 31 - Earnings Summary
Jefferies dips after Q2 results
Jefferies misses revenue estimates in Q2 despite advisory, equities strength
Taysha Gene Therapies slides on $200 mln stock offering launch
Jefferies quarterly profit more than doubles on dealmaking, equities strength
Brief: Jefferies Q2 Revenue USD 2,206.451 Million Vs. IBES Estimate USD 2,299 Million
Brief: Jefferies Says Q2 Revenue $2.21 Billion Versus IBES Estimate $2.3 Billion
U.S. STOCKS ON THE MOVE-Broadcom, Micron, Qualcomm
PREVIEW: Jefferies Q2 EPS, revenue seen rising but shares sink
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies, Take-Two, Accenture
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies
U.S. STOCKS ON THE MOVE-Pfizer, Accenture, Kroger
UBS downgrades Jefferies rating to 'neutral' after sharp rally
Enliven soars after boosted equity raise for leukemia drug
Enliven falls after $400 mln equity raise to fund leukemia drug
Enliven Therapeutics slips on $250 mln equity offering
Brief: Jpmorgan, Jefferies Plan Venezuela Trips As Investors Rush In - Bloomberg News
Jade Biosciences drops on $150 mln equity raise